RAC 2.20% $1.78 race oncology ltd

Ann: Race In-person Investor Briefing Invitation Perth, page-12

  1. 2,924 Posts.
    lightbulb Created with Sketch. 3561
    Yes, must be getting an announcement tomorrow prior to the briefing session in the afternoon.

    There's no way MST could know this / present this otherwise. Seems bizarre to publish this updated clinical program, I would have thought the clinical P1a/b data would inform future programs? This could all be out the window again in 6 months...

    https://hotcopper.com.au/data/attachments/6281/6281018-f540b0096976bb87b1470c2a546dd79f.jpg

    https://hotcopper.com.au/data/attachments/6281/6281021-508e7e1591e3e29134d9bc88002df216.jpg
    https://hotcopper.com.au/data/attachments/6281/6281022-bdfe2ecfc2fee2f4bb9d89523d585533.jpg


    We haven't heard anything about melanoma since June 2022:

    https://raceoncology.com/zantrene-improves-cancer-immunotherapy-in-a-mouse-model-of-treatment-resistant-melanoma/

    https://hotcopper.com.au/data/attachments/6281/6281026-170cc969322b6eed1268380222cf915f.jpg

    https://hotcopper.com.au/data/attachments/6281/6281037-93472f49080466450b773e661ad038ca.jpg

    Keytruda synergy pls....
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.